Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation

International Journal of Women's Health

Volumn 3, Issue 1, 2011, Pages 133-138

  Gooch, Katherine L ^a   Notario, Gerard F ^a   Schulz, Gregory ^a   Gudkov, Konstantin M ^a   Buesch, Katharina ^b   Khong, Hoa ^c   Campbell, Andrew ^a  

^a ABBOTT LABORATORIES   (United States)

^b ABBOTT GMBH AND CO KG   (Germany)

^c Vcomtech Inc   (Canada)

Author keywords

Prematurity; Protective risk factors; Respiratory syncytial virus; Russian Federation

Indexed keywords

ARTICLE; BODY WEIGHT; BREAST FEEDING; CHILD HOSPITALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOSPITALIZED INFANT; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INFANT; INFECTION RISK; INFECTION SENSITIVITY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE PREGNANCY; PREMATURITY; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; RUSSIAN FEDERATION; SIBLING; TERM BIRTH;

EID: 79958038991     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S16608     Document Type: Article

References (26)

1. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543-546.
2. Simoes EAF. Respiratory syncytial virus infection. Lancet. 1999;354: 847-852.
3. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588-598.
4. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, editors. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders Co; 1998.
5. Mlinaric-Galinovic G. Eleven consecutive years of respiratory syncytial virus outbreaks in Croatia. Pediatr Int. 2009;51:237-240.
6. Everard M. Diagnosis, Admission, discharge. Paediatr Respir Rev. 2009;10 Suppl 1:18-20.
7. Langley JM, Wang EE, Law BJ, et al. Economic evaluation of respiratory syncytial virus infection in Canadian children: A Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr. 1997;131:113-117.
8. Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: An analysis of national databases. Pharmacoeconomics. 2004;22:275-284.
9. Langley JM, LeBlanc JC, Smith B, Wang EE. Increasing incidence of hospitalization for bronchiolitis among Canadian children. 1980-2000. J Infect Dis. 2003;188:1764-1767.
10. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children 1980-1986. JAMA. 1999;282:1440-1446.
11. Handforth J, Sharland M, Friedland JS. Prevention of respiratory syncytial virus in children. BMJ. 2004;328:1026-1027.
12. Georgescu G, Chemaly RF. Palivizumab: Where to from here? Expert Opin Biol Ther. 2009;9:139-147.
13. Stensballe L, Devasundaram JK, Simoes EAF. Respiratory syncytial virus epidemics: The ups and downs of a season virus. Pediatr Infect Dis J. 2003;22:S21-S32.
14. Respiratory syncytial virus activity - United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep. 2000;49:1091-1093.
15. Spense L, Barratt B. Respiratory syncytial virus associated with acute respiratory infection in Trinidadian patients. Am J Epidemiol. 1968;88:257-266.
16. World Health Organization. Mortality Country Fact Sheet: Germany (2006). Available at: http://www.who.int/whosis/mort/profiles/mort_euro_deu_germany.pdf. Accessed March 2, 2011.
17. World Health Organization. Mortality Country Fact Sheet: United States (2006). Available at: http://www.who.int/whosis/mort/profiles/mort_amro_usa_unitedstatesofamerica.pdf. Accessed March 2, 2011.
18. World Health Organization. Mortality Country Fact Sheet: Russian Federation (2006). Available at: http://www.who.int/whosis/mort/profiles/mort_euro_rus_russianfed.pdf. Accessed March 2, 2011.
19. Tatochenko V, Uchaikin V, Gorelov A, et al. Epidemiology of respiratory syncytial virus in children #2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: A prospective, multicenter study. Clin Epidemiol. 2010;2:221-227.
20. Gorbunov SG, Gorelov AV, Kosorotikova AI. Etiological structure of acute respiratory virus infections in children hospitalized in 1981-1999. Zh Mikrobiol (Moscow). 2001;6:25-27.
21. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: Infants with predisposing conditions. Pediatr Infect Dis J. 2003;22:S33-S39.
22. Cilla G, Sarasua A, Montes M, et al. Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiol Infect. 2006;134:506-513.
23. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23:806-814.
24. Figueras-Aloy J, Carbonell-Estrany X, Quero J, et al; IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23:815-820.
25. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jimenez J. Risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J. 2008;27:788-793.
26. Sampalis JS, Langley J, Carbonell-Estrany X, et al. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making. 2008;28:471-480.